Three-Friend Medical: Signed strategic cooperation and distribution agreement with South Korean Seegene Bio.

SanYou Medical announced that on December 2, 2025, the company signed a "Strategic Cooperation and Distribution Agreement" with South Korea's Cellpile Biotech Co., Ltd., granting exclusive and non-transferable distribution rights for Novosis products in mainland China. The authorization period is six years from the date the product obtains a medical device registration certificate from the China Food and Drug Administration. Novosis is a recombinant human bone morphogenetic protein BMP-2 biological material product that promotes new bone formation. This collaboration will enrich the company's product line and improve its layout in the field of orthopedic biological materials, but the uncertainty of product registration and market approval may affect performance, and the specific impact on performance cannot be predicted at this time.